<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 21 Apr 2026 10:52:20 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/tamoxifen/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[The Truth About Tamoxifen]]></title><description><![CDATA[Tamoxifen is the most prescribed drug in the world for people with hormone receptor positive breast cancer. This drug has many potentially serious side effects, including cancer. Learn more in this article.]]></description><link>http://direct.ecency.com/tamoxifen/@cancerwisdom/the-truth-about-tamoxifen</link><guid isPermaLink="true">http://direct.ecency.com/tamoxifen/@cancerwisdom/the-truth-about-tamoxifen</guid><category><![CDATA[tamoxifen]]></category><dc:creator><![CDATA[cancerwisdom]]></dc:creator><pubDate>Mon, 27 Jan 2020 17:18:45 GMT</pubDate></item><item><title><![CDATA[Tamoxifen Market: Regional Insights,Competitive Landscape,Opportunity Analysis 2026]]></title><description><![CDATA[Tamoxifen is a type of selective estrogen receptor modulator. The main pharmacologic action of Tamoxifen is to block the growth-promoting effects of estrogens on breast cancer. In bone cells, selective]]></description><link>http://direct.ecency.com/tamoxifen/@chaitanyag/tamoxifen-market-regional-insights-competitive-landscape-opportunity-analysis-2026</link><guid isPermaLink="true">http://direct.ecency.com/tamoxifen/@chaitanyag/tamoxifen-market-regional-insights-competitive-landscape-opportunity-analysis-2026</guid><category><![CDATA[tamoxifen]]></category><dc:creator><![CDATA[chaitanyag]]></dc:creator><pubDate>Tue, 16 Oct 2018 06:37:24 GMT</pubDate></item><item><title><![CDATA[Tamoxifen in World Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022]]></title><description><![CDATA[DecisionDatabases.com announces a new report “World Tamoxifen Market Research Report 2022 (covering USA, Europe, China, Japan, India, South East Asia and etc)” added to its database. The report provides]]></description><link>http://direct.ecency.com/tamoxifen/@mera/tamoxifen-in-world-market-2017-by-manufacturers-regions-type-and-application-forecast-to-2022</link><guid isPermaLink="true">http://direct.ecency.com/tamoxifen/@mera/tamoxifen-in-world-market-2017-by-manufacturers-regions-type-and-application-forecast-to-2022</guid><category><![CDATA[tamoxifen]]></category><dc:creator><![CDATA[mera]]></dc:creator><pubDate>Wed, 10 Jan 2018 04:42:06 GMT</pubDate></item><item><title><![CDATA[Introducing Tamoxifen Side Effects]]></title><description><![CDATA[ Tamoxifen (Nolvadex) endorsed for the anticipation and treatment of bosom malignancy in men and ladies, and once in a while, to empower ovulation in ladies.   The Dangers of Actaea: Before]]></description><link>http://direct.ecency.com/tamoxifen/@ajam/introducing-tamoxifen-side-effects</link><guid isPermaLink="true">http://direct.ecency.com/tamoxifen/@ajam/introducing-tamoxifen-side-effects</guid><category><![CDATA[tamoxifen]]></category><dc:creator><![CDATA[ajam]]></dc:creator><pubDate>Thu, 28 Sep 2017 21:54:33 GMT</pubDate><enclosure url="https://images.ecency.com/p/23KQwnog7Q1jpM7UHxWfdG9Z1Pdk74nts8wouf8sJN6B95BkDdmBzSmszzALbUhjD5PAmY3H7xaz2nAKirvuCzx199tiJnz?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>